Additionally, activation of the HGF-MET pathway by overexpression and up regulation has been described as the escape resistance mechanism of tumor cells against inhibition of the EGFR, RAS-RAF-MEK, and Akt–mTOR (mammalian target of rapamycin) pathways [155,156]. The gene discussed is AKT1; the disease is neoplasm.